These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 20044532

  • 21. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Neuronal gap junctions are required for NMDA receptor-mediated excitotoxicity: implications in ischemic stroke.
    Wang Y, Denisova JV, Kang KS, Fontes JD, Zhu BT, Belousov AB.
    J Neurophysiol; 2010 Dec 19; 104(6):3551-6. PubMed ID: 20943940
    [Abstract] [Full Text] [Related]

  • 24. The rise and fall of NMDA antagonists for ischemic stroke.
    Hoyte L, Barber PA, Buchan AM, Hill MD.
    Curr Mol Med; 2004 Mar 19; 4(2):131-6. PubMed ID: 15032709
    [Abstract] [Full Text] [Related]

  • 25. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
    Dall'Igna OP, Da Silva AL, Dietrich MO, Hoffmann A, de Oliveira RV, Souza DO, Lara DR.
    Psychopharmacology (Berl); 2003 Mar 19; 166(3):258-63. PubMed ID: 12589526
    [Abstract] [Full Text] [Related]

  • 26. Ethanol pre-exposure suppresses HIV-1 glycoprotein 120-induced neuronal degeneration by abrogating endogenous glutamate/Ca2+-mediated neurotoxicity.
    Belmadani A, Zou JY, Schipma MJ, Neafsey EJ, Collins MA.
    Neuroscience; 2001 Mar 19; 104(3):769-81. PubMed ID: 11440808
    [Abstract] [Full Text] [Related]

  • 27. Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures.
    Milhaud D, Fagni L, Bockaert J, Lafon-Cazal M.
    Neuropharmacology; 2000 Sep 19; 39(12):2244-54. PubMed ID: 10974308
    [Abstract] [Full Text] [Related]

  • 28. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex.
    Harada H, Kelly PJ, Cole DJ, Drummond JC, Patel PM.
    Anesth Analg; 1999 Dec 19; 89(6):1442-7. PubMed ID: 10589624
    [Abstract] [Full Text] [Related]

  • 29. Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter.
    Bakiri Y, Hamilton NB, Káradóttir R, Attwell D.
    Glia; 2008 Jan 15; 56(2):233-40. PubMed ID: 18046734
    [Abstract] [Full Text] [Related]

  • 30. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo.
    Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT.
    J Neurosci; 2007 Mar 14; 27(11):2846-57. PubMed ID: 17360906
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists.
    Eriksson C, Zou LP, Ahlenius S, Winblad B, Schultzberg M.
    Brain Res Mol Brain Res; 2000 Dec 28; 85(1-2):103-13. PubMed ID: 11146112
    [Abstract] [Full Text] [Related]

  • 32. Reducing conditions significantly attenuate the neuroprotective efficacy of competitive, but not other NMDA receptor antagonists in vitro.
    Pringle AK, Self J, Eshak M, Iannotti F.
    Eur J Neurosci; 2000 Nov 28; 12(11):3833-42. PubMed ID: 11069578
    [Abstract] [Full Text] [Related]

  • 33. bFGF enhances the protective effects of MK-801 against ischemic neuronal injury in vitro.
    Barth A, Barth L, Morrison RS, Newell DW.
    Neuroreport; 1996 Jun 17; 7(9):1461-4. PubMed ID: 8856698
    [Abstract] [Full Text] [Related]

  • 34. N-methyl-D-aspartate receptor antagonist reduces nitrotyrosine formation in caudate-putamen in rat focal cerebral ischemia-reperfusion.
    Hirabayashi H, Takizawa S, Fukuyama N, Nakazawa H, Shinohara Y.
    Neurosci Lett; 2001 Feb 16; 299(1-2):159-61. PubMed ID: 11166962
    [Abstract] [Full Text] [Related]

  • 35. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
    Cho Y, Ueda T, Mori A, Shimizu H, Haga Y, Yozu R.
    J Vasc Surg; 2005 Oct 16; 42(4):765-71. PubMed ID: 16242566
    [Abstract] [Full Text] [Related]

  • 36. N-methyl-D-aspartate-induced excitotoxicity in adult rat retina is antagonized by single systemic injection of MK-801.
    Sun Q, Ooi VE, Chan SO.
    Exp Brain Res; 2001 May 01; 138(1):37-45. PubMed ID: 11374081
    [Abstract] [Full Text] [Related]

  • 37. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
    Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA.
    Hippocampus; 2006 May 01; 16(10):834-42. PubMed ID: 16897723
    [Abstract] [Full Text] [Related]

  • 38. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
    Pawley AC, Flesher S, Boegman RJ, Beninger RJ, Jhamandas KH.
    Br J Pharmacol; 1996 Mar 01; 117(6):1059-64. PubMed ID: 8882597
    [Abstract] [Full Text] [Related]

  • 39. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease.
    Armentero MT, Fancellu R, Nappi G, Bramanti P, Blandini F.
    Neurobiol Dis; 2006 Apr 01; 22(1):1-9. PubMed ID: 16289868
    [Abstract] [Full Text] [Related]

  • 40. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J, Henman MC, Doyle KM, Strbian D, Kirby BP, Tatlisumak T, Shaw GG.
    Brain Res; 2004 Dec 10; 1029(1):84-92. PubMed ID: 15533319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.